Clinical Trials Directory

Trials / Completed

CompletedNCT01742312

Effects of Chemotherapy on Muscle Mass and Exercise Performance in Patients With Oesophageal Cancer.

Effect of Neoadjuvant Chemotherapy on Muscle Mass and Peri-operative Cardiorespiratory Performance in Patients Undergoing Oesophageal Cancer- a Pilot Study

Status
Completed
Phase
Study type
Observational
Enrollment
25 (actual)
Sponsor
University of Nottingham · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Curative treatment for oesophageal cancer involves undertaking chemotherapy followed by an operation to remove the tumour. Chemotherapy has several effects upon the body, including effects upon the systems that control the creation and breakdown of muscle. We aim to review these effects by recording changes in the amount of exercise patients are able to undertake after chemotherapy and reviewing changes in muscle mass.

Detailed description

We aim to review the effects of chemotherapy on skeletal muscle mass and cardio-respiratory performance in patients with oesophageal adenocarcinoma. All patients will be assessed by a Consultant Anaesthetist and a medical member of the Research team before commencing chemotherapy and after finishing their course. These assessments include a nutritional assessment, performance status assessments, blood assays, dual energy X-ray absorptiometry (DEXA) scans, cardio-pulmonary exercise (CPEX) testing and a muscle biopsy.

Conditions

Interventions

TypeNameDescription
RADIATIONDEXA scanall patients will undertake a full body DEXA scan before and after chemotherapy
PROCEDUREMuscle biopsyAll patients will have a muscle biopsy before and after chemotherapy
OTHERcardio-pulmonary exercise testing (CPEX)patients will undertake exercise in the form of an exercise bike whilst having their cardiac and ventilatory performance analysed. This will take place before and after neoadjuvant chemotherapy

Timeline

Start date
2011-10-01
Primary completion
2013-01-01
Completion
2013-01-01
First posted
2012-12-05
Last updated
2016-02-18

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01742312. Inclusion in this directory is not an endorsement.